The European Commission has approved Sanofi’s Wayrilz (rilzabrutinib), a new (novel) oral Bruton’s tyrosine kinase (BTK) inhibitor, as an additional treatment for patients with Immune Thrombocytopenia
Industry leaders share how AI, GCCs, local manufacturing, and quality-first strategies are reshaping India’s life sciences, biometrics, medical devices, and lab solutions ecosystem.
Biocon Biologics has secured full and exclusive global rights to its biosimilar Adalimumab, marketed as Hulio, strengthening its control over one of the world’s most widely used biologic therapies. The rights were obtained through an expande...
Emcure Pharmaceuticals is launching Poviztra, a new version of Novo Nordisk’s GLP-1 weight management drug, in India. This move increases Emcure's role in the quickly growing market for obesity treatments
Senores Pharmaceuticals acquires Apnar Pharma in a move that strengthens its footprint across regulated global markets. The company has signed a definitive agreement to acquire a 100 percent equity stake in Apnar Pharma Private Limited, along...
Bristol Myers Squibb has launched Mosaic AI content hub, a first-of-its-kind, AI-powered platform designed to reshape how pharmaceutical content is created and delivered. Developed with Accenture, the new hub marks a major step forward in...
Biocon Biologics Limited, an integrated global biopharmaceutical group and a subsidiary of Biocon Limited have been named under IAM (Intellectual Asset Management). IAM is a leader in international intellectual property publications, to Biocon...
Lupin, a global pharmaceutical company, is making a substantial move towards sustainability. The Science Based Targets initiative (SBTi) certified its greenhouse gas reduction plan, and includes Scope 1, Scope 2, and Scope 3 emissions...
Piramal Pharma Solutions NPS has reached a strong 55 for FY2025, signaling high customer loyalty and trust across its global operations. Announced today, the result highlights the company’s growing reputation as a reliable global CDMO and...
Roche has announced fresh momentum in clinical diagnostics with CE Mark approval for its new mass spectrometry reagent pack, a move that strengthens its position in mass spectrometry testing. The approval expands what is now the broadest IVD...
.jpg)
, CDSCO.jpg)